Skip to main content
SpringerLink
Log in

Composition Optimization and Stability Testing of a Parenteral Antifungal Solution based on a Ternary Solvent System

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

An intravenous solution is a dosage forms intended for administration into the bloodstream. This route is the most rapid and the most bioavailable method of getting drugs into systemic circulation, and therefore it is also the most liable to cause adverse effects. In order to reduce the possibility of side effects and to ensure adequate clinical dosage of the formulation, the primarily formulated composition should be optimized. It is also important that the composition should retain its therapeutic effectiveness and safety throughout the shelf-life of the product. This paper focuses on the optimization and stability testing of a parenteral solution containing miconazole and ketoconazole solubilized with a ternary solvent system as model drugs. Optimization of the solvent system was performed based on assessing the risk/benefit ratio of the composition and its properties upon dilution. Stability tests were conducted based on the EMEA (European Medicines Agency) “guideline on stability testing: stability testing of existing active substances and related finished products”. Experiments show that both the amount of co-solvent and surface active agent of the solvent system could substantially be reduced, while still maintaining adequate solubilizing power. It is also shown that the choice of various containers affects the stability of the compositions. It was concluded that by assessing the risk/benefit ratio of solubilizing power versus toxicity, the concentration of excipients could be considerably decreased while still showing a powerful solubilizing effect. It was also shown that a pharmaceutically acceptable shelf-life could be assigned to the composition, indicating good long-term stability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Yalkowsky SH, Krzyzaniak JF, Ward GH. Formulation-related problems associated with intravenous drug delivery. J Pharm Sci. 1998;87:787–96.

    Article  CAS  PubMed  Google Scholar 

  2. Egger-Heigold B. The effect of excipients on pharmacokinetic parameters of parenteral drugs (dissertation). Basel; 2005.

  3. Torrado S, Torrado S, Cadorniga R, Torrado JJ. Formulation parameters of albendazole solution. Int J Pharm. 1996;140:45–50.

    Article  CAS  Google Scholar 

  4. Alvarez-Núñez FA, Yalkowsky SH. Buffer capacity and precipitation control of pH solubilized phention formulations. Int J Pharm. 1999;185:45–9.

    Article  PubMed  Google Scholar 

  5. Sweetana S, Akers MJ. Solubility principles and practice for parenteral drug dosage form development. PDA J Pharm Sci Tech. 1999;50(5):330–42.

    Google Scholar 

  6. Ni N, Sanghvi T, Yalkowsky SH. Solubilization and preformulation of carbendazim. Int J Pharm. 2002;244:99–104.

    Article  CAS  PubMed  Google Scholar 

  7. Rangel-Yagui CO, Pessoa-Jr A, Tavares LC. Micellar solubilization of drugs. J Pharm Pharmaceut Sci. 2005;8(2):147–63.

    CAS  Google Scholar 

  8. Lamas MC, Villaggi L, Nocito I, Bassani G, Leonardi D, Pascutti F, et al. Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. Int J Pharm. 2006;307:239–43.

    Article  CAS  PubMed  Google Scholar 

  9. Lin HS, Chean CS, Ng YY, Chan SY, Ho PC. 2-Hydroxypropyl-β-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid. J Clin Pharm Ther. 2000;25:265–9.

    Article  CAS  PubMed  Google Scholar 

  10. Brazeau GA, Cooper B, Svetic KA, Smith CL, Gupta P. Current perspectives on pain upon injection of drugs. J Pharm Sci. 1998;87:667–77.

    Article  CAS  PubMed  Google Scholar 

  11. Kryzaniak JF, Raymond DM, Yalkowsky SH. Lysis of human red blood cells 2: effect of contact time on cosolvent induced hemolysis. Int J Pharm. 1997;52:193–200.

    Article  Google Scholar 

  12. Amin K, Dannenfelser RM. In vitro hemolysis: guidance for the pharmaceutical scientist. J Pharm Sci. 2006;95:1173–6.

    Article  CAS  PubMed  Google Scholar 

  13. Krzyzaniak JF, Alvarez Nunez FA, Raymond DM, Yalkowsky SH. Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data. J Pharm Sci. 1997;86:1215–7.

    Article  CAS  PubMed  Google Scholar 

  14. Lowe K, Furmidge B, Thomas S. Haemolytic properties of pluronic surfactants and effects of purification. Artif Cell Blood Substit Immobil Biotechnol. 1995;23:135–9.

    Article  CAS  Google Scholar 

  15. Al-Assadi H, Baillie AJ, Florence AT. The haemolytic activity of non-ionic surfactants. Int J Pharm. 1989;53:161.

    Google Scholar 

  16. Riess JG, Pace S, Zarif L. Highly effective surfactants with low hemolytic activity. Adv Mat. 1991;3:249–51.

    Article  CAS  Google Scholar 

  17. Ohnishi M, Sagitani H. The effect of nonionic surfactant structure on hemolysis. J Am Oil Chem Soc. 1993;70:679–84.

    Article  CAS  Google Scholar 

  18. Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D. Seventy-two-hour stability of Taxol® in 5% dextrose or 0.9% sodium chloride in Viaflo®, Freeflex®, Ecoflac® and Macoflex N® non-PVC bags. J Clin Pharm Ther. 2005;30:155–458.

    Article  Google Scholar 

  19. McGookin AG, Millership JS, Scott EM. Miconazole sorption to intravenous infusion sets. J Clin Pharm Ther. 1989;12:433–7.

    Article  Google Scholar 

  20. Kovács K, Stampf Gy, Klebovich I, Antal I, Ludányi K. Aqueous solvent system for the solubilization of azole compounds. Eur J Pharm Sci. 2009;36:352–8.

    Article  PubMed  Google Scholar 

  21. Piel G, Evrard B, Fillet M, Llabres G, Delattre L. Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. Int J Pharm. 1998;169:15–22.

    Article  CAS  Google Scholar 

  22. Taneri F, Güneri T, Aigner Z, Kata M. Influence of cyclodextrin complexation on the physicochemical and biopharmaceutical properties of ketoconazole. J Incl Phenom Macro Chem. 2003;47:15–23.

    Article  CAS  Google Scholar 

  23. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001;37:1590–8.

    Article  CAS  PubMed  Google Scholar 

  24. Gupta SL, Patel JP, Jones DL, Partipilo RW. Parenteral formulation development of renin inhibitor Abbott-72517. PDA J Pharm Sci Tech. 1994;48:86–91.

    CAS  Google Scholar 

  25. Barillaro V, Bertholet P, de Hassonville SH. Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. J Pharm Pharmaceut Sci. 2004;7:378–88.

    CAS  Google Scholar 

  26. Crane IM, Mulhern MG, Nema S. Stability of reconstituted parecoxib for injection with commonly used diluents. J Clin Pharm Ther. 2003;28:363–9.

    Article  CAS  PubMed  Google Scholar 

  27. Krishna G, Hodnick WF, Lang W, Lin X, Karra S, Mao J, et al. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M. AAPS PharmsciTech. 2001;2(3):article 14.

    Article  Google Scholar 

  28. Guideline on stability testing: stability testing of existing active substances and related finished products (CPMP/QWP/122/02)

  29. Amin K, Dannenfelser RM. In vitro hemolysis: guidance for the pharmaceutical scientist. Wiley InterScience. 2007. doi: 10.1002/jps.20627.

  30. Krzyzaniak JF, Raymond DM, Yalkowsky SH. Lysis of human red blood cells 2 effect of contact time on cosolvent induced hemolysis. Int J Pharm. 1997;152:193–200.

    Article  CAS  Google Scholar 

  31. Krzyzaniak JF, Raymond DM, Yalkowsky SH. Lysis of human red blood cells 3 effect of contact time on surfactant induced hemolysis. J Pharm Sci Technol. 1998;52:66–9.

    CAS  Google Scholar 

  32. Ross BP, Braddy AC, McGeary RP, Blanchfield JT, Prokai L, Toth I. Micellar aggregation and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-conjugated fatty acids: Correlation with hemolytic potency and implications for drug delivery. Mol Pharm. 2004;1:233–45.

    Article  CAS  PubMed  Google Scholar 

  33. Yalkowsky SH. Solubility and solubilization in aqueous media. New York: Oxford University Press; 1999.

    Google Scholar 

  34. Völgyi G, Deák K, Vámos J, Valkó K, Takács-Novák K. RPTLC determination of log P of structurally diverse neutral compounds. J Planar Chrom. 2008;21:143–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Semmelweis University, 7-9 Hőgyes E. street, H-1092, Budapest, Hungary

    Kristóf Kovács, István Antal, György Stampf, Imre Klebovich & Krisztina Ludányi

Authors
  1. Kristóf Kovács
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. István Antal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. György Stampf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Imre Klebovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Krisztina Ludányi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristóf Kovács.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kovács, K., Antal, I., Stampf, G. et al. Composition Optimization and Stability Testing of a Parenteral Antifungal Solution based on a Ternary Solvent System. AAPS PharmSciTech 11, 285–293 (2010). https://doi.org/10.1208/s12249-009-9368-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-009-9368-1

Key words

Search

Navigation